Abstract
This chapter evaluates differences between oral supplementation with calcifediol (25-hydroxyvitamin D) and vitamin D3 (cholecalciferol). Oral supplementation with calcifediol results in an immediate and sustained increase in serum 25-hydroxyvitamin D concentrations. This may be relevant in clinical care as higher circulating level of 25-hydroxyvitamin D can be reached much faster than on the standard supplementation with vitamin D3. However, whether calcifediol has additional benefits superior to vitamin D3 will need further investigation in an equivalent dose comparison trial.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dawson-Hughes B, Mithal A, Bonjour JP, et al. IOF position statement: vitamin D recommendations for older adults. Osteoporos Int. 2010;21:1151–4.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
Bischoff Ferrari HA, Burckhardt P, Quack-Loetscher K, et al. Vitamin D deficiency: evidence, safety, and recommendations for the Swiss population Report written by a group of experts on behalf of the Federal Commission for Nutrition (FCN) 2012 Approved by the Federal Commission for Nutrition on November 3, 2011. http://www.bag.admin.ch/themen/ernaehrung_bewegung/05207/13246/index.html?lang=en. Last accessed 16 Oct 2012.
Bischoff-Ferrari HA, Orav EJ, Willett WC, et al. A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med. 2012;367(1):40–9.
Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E, Willett WC. Benefit-risk assessment of vitamin D supplementation. Osteoporos Int. 2010;21:1121–32.
Gallagher JC, Sai A, Templin 2nd T, Smith L. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Ann Intern Med. 2012;156:425–37.
Haddad Jr JG, Rojanasathit S. Acute administration of 25-hydroxycholecalciferol in man. J Clin Endocrinol Metab. 1976;42:284–90.
Hahn TJ, Halstead LR, Teitelbaum SL, Hahn BH. Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration. J Clin Invest. 1979;64:655–65.
Stamp TC, Haddad JG, Twigg CA. Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D. Lancet. 1977;1:1341–3.
Colodro IH, Brickman AS, Coburn JW, Osborn TW, Norman AW. Effect of 25-hydroxy-vitamin D3 on intestinal absorption of calcium in normal man and patients with renal failure. Metabolism. 1978;27:745–53.
Stamp TC. Intestinal absorption of 25-hydroxycholecalciferol. Lancet. 1974;2:121–3.
Francis RM, Peacock M, Storer JH, Davies AE, Brown WB, Nordin BE. Calcium malabsorption in the elderly: the effect of treatment with oral 25-hydroxyvitamin D3. Eur J Clin Invest. 1983;13:391–6.
Bischoff-Ferrari HA, Dawson-Hughes B, Stöcklin E, et al. Oral supplementation with 25(OH)D3 versus vitamin D3: effects on 25(OH)D levels, lower extremity function, blood pressure and markers of innate immunity. J Bone Miner Res. 2011; [Epub ahead of print].
Cashman KD, Seamans KM, Lucey AJ, et al. Relative effectiveness of oral 25-hydroxyvitamin D3 and vitamin D3 in raising wintertime serum 25-hydroxyvitamin D in older adults. Am J Clin Nutr. 2012;95:1350–6.
Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab. 2000;85:3011–9.
Sosa M, Lainez P, Arbelo A, Navarro MC. The effect of 25-dihydroxyvitamin D on the bone mineral metabolism of elderly women with hip fracture. Rheumatology (Oxford). 2000;39:1263–8.
Barger-Lux MJ, Heaney RP, Dowell S, Chen TC, Holick MF. Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int. 1998;8:222–30.
Smith JE, Goodman DS. The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma. J Clin Invest. 1971;50:2159–67.
Garcia-Delgado I, Prieto S, Gil-Fraguas L, Robles E, Rufilanchas JJ, Hawkins F. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int. 1997;60:155–9.
Talalaj M, Gradowska L, Marcinowska-Suchowierska E, Durlik M, Gaciong Z, Lao M. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Transplant Proc. 1996;28:3485–7.
Hillman LS, Hollis B, Salmons S, et al. Absorption, dosage, and effect on mineral homeostasis of 25-Âhydroxycholecalciferol in premature infants: comparison with 400 and 800 IU vitamin D2 supplementation. J Pediatr. 1985;106:981–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Bischoff-Ferrari, H.A. (2013). Chapter Relative Effects of Vitamin D3 and Calcifediol. In: Burckhardt, P., Dawson-Hughes, B., Weaver, C. (eds) Nutritional Influences on Bone Health. Springer, London. https://doi.org/10.1007/978-1-4471-2769-7_18
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2769-7_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2768-0
Online ISBN: 978-1-4471-2769-7
eBook Packages: MedicineMedicine (R0)